CRISPR cures for sickle cell disease raise equity concerns

With CRISPR cures for sickle cell disease on the horizon, the gene-editing world must grapple with tough questions of equity and access.

Related Keywords

United States ,Nigeria ,India ,Philadelphia ,Pennsylvania ,University Of Cape Town ,Western Cape ,South Africa ,Vietnam ,Republic Of ,Riverside Church ,Tanzania ,University Of Pennsylvania ,London ,City Of ,United Kingdom ,Mississippi ,Tanzanian ,American ,Martin Luther King Jr ,Alexis Thompson ,Novartis Zolgensma ,Emily Turner ,Ambroise Wonkam ,Gautam Dongre ,Vertex Pharmaceuticals ,African Society Of Human Genetics ,Third International Summit On Human Genome Editing ,National Institutes Of Health ,Drug Administration ,Claire Booth Of University College London ,Johns Hopkins School Of Medicine ,Gates Foundation ,Victoria Gray ,Third International Summit ,Human Genome Editing ,Claire Booth ,University College London ,Nobel Prize Winning ,Martin Luther King ,Saharan Africa ,Johns Hopkins School ,Cape Town ,African Society ,National Institutes ,Arafa Salim Said ,